This week’s Research Ethics Roundup highlights ethical issues related to clinical trials studying the psychedelics, as well as moves toward making research more efficient, innovative, and transparent.
The Trip Treatment: Author and journalist Michael Pollan reports on the reemergence of research on psychedelics. In this article from The New Yorker, Pollan shares stories of participants and their experiences in clinical trials studying the psychedelic psilocybin.
Clinical-Trial Specialist Could Be Next FDA Chief: In this article from Nature, journalist Heidi Ledford provides background on Robert Califf, who was recently [...] Read more
by Susan Gilbert, Public Affairs and Communications Manager at The Hastings Center
A curious aspect of the debate over the use of animals in research is that the two “sides” see themselves as making different kinds of arguments when in fact they have some fundamental similarities. For example, a recent post in Ampersand discussed the line between emotions and fact in debates over the use of animals in research. It referred to the keynote speech given by Allyson Bennett, PhD, at the 2013 Institutional Animal Care and Use Committee (IACUC) Conference[...] Read more